GlaxoSmithKline hits 20% upper circuit on posting 400% jump in Q3 PAT
The company posted a multifold jump per cent in consolidated net profit to Rs 230 crore as compared to Rs 46 crore a year ago ...
PharmiWeb5d
The Rise of Targeted Therapies: Transforming the Ovarian Cancer Drugs Market
Ovarian cancer continues to pose a significant challenge in the medical field, remaining one of the leading causes of death ...
GlaxoSmithKline Pharmaceuticals shares hit 20% upper circuit as profit jumps fivefold in Q3FY25
GlaxoSmithKline Pharmaceuticals shares surged 20% to ₹2,421.30 after a strong Q3FY25 performance, reporting a 400% rise in ...
GSK shares rise over 5% after Q4 results
GlaxoSmithKline plc (NYSE: NYSE:GSK) shares gained 5.65% after the pharmaceutical giant reported fourth quarter revenue that beat analyst estimates, despite earnings falling short of expectations.
India Infoline5d
Glaxosmithkline Pharmaceuticals Ltd Summary
Their prescription medicines range across therapeutic ... This follows a global transaction between GlaxoSmithKline plc, UK (GSK) and Novartis AG, Switzerland (Novartis) which was completed ...
Seeking Alpha3d
IONS Ionis Pharmaceuticals, Inc.
It also develops medicines for various indications that ... AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was ...
Investing20d
Best Cheap UK Stocks Under £20 with High Upside (February2025)
It also provides medicines for HIV, oncology ... The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in ...